# Antibiotic Treatment and Intravenous Immunoglobulin Trial for PANDAS

> **NCT01769027** · PHASE2 · WITHDRAWN · sponsor: **CNS Onlus**

## Conditions studied

- Pandas

## Interventions

- **DRUG:** Sertraline+Antibiotic (penicillin/azithromycin)
- **DRUG:** Sertraline+placebo
- **BIOLOGICAL:** IVIG

## Key facts

- **NCT ID:** NCT01769027
- **Lead sponsor:** CNS Onlus
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-06
- **Primary completion:** 2013-12
- **Final completion:** 2016-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No participants enrolled
- **Last updated:** 2023-02-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01769027

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01769027, "Antibiotic Treatment and Intravenous Immunoglobulin Trial for PANDAS". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01769027. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*